| http://www.w3.org/ns/prov#value | - Based on the encouraging outcome of this initial trial, we conducted a Phase I study in the U.S., EU and other countries to evaluate Plasmin in the treatment of aPAO, a condition in which arterial blood flow to extremities, usually the legs, becomes blocked by a clot.
|
